Body weight, median (IQR), remained stable during the study period (65.8 kg [55.377.5] and 65.3 kg [56.5-78.5] for dulaglutide and placebo, respectively)
Contact us today to receive a consultation on which weight loss program, hormone treatment or anti-aging program is best for you
Are products COA-backed
Thats why we offer free case reviews and never charge fees unless we win
Both of these medications contain semaglutide, a synthetic version of the GLP-1 hormone, but they are prescribed at different doses depending on the patients medical needs
Furthermore, a recent extensive cohort study involving over 33,000 GLP-1 RA users diagnosed with diabetes over a 9-year period indicated no significant increase in pancreatic cancer risk associated with GLP-1 RA use, as evidenced by an HR of 0.50 compared to basal insulin [60]